Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02048488
Title A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Tesaro, Inc.
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | GBR | ESP

Additional content available in CKB BOOST